Press Releases :: Avalo Therapeutics, Inc. (AVTX)

Feb 3, 2020 4:15 pm EST

Cerecor and Aevi Genomic Medicine Complete Merger

Dec 5, 2019 8:45 am EST

Cerecor to Acquire Aevi Genomic Medicine

Nov 14, 2019 6:30 am EST

Cerecor Reports Third Quarter 2019 Results

Nov 11, 2019 6:30 am EST

Cerecor Announces Clinical Updates on CERC-301 and CERC-802

Nov 4, 2019 6:30 am EST

Cerecor Closes Deal to Sell Pediatric Portfolio

Oct 14, 2019 6:30 am EDT

Cerecor To Sell Pediatric Portfolio to AYTU BioScience

Aug 21, 2019 6:30 am EDT

Cerecor Receives Fast Track Designation from FDA for CERC-802 for the Treatment of Mannose-Phosphate Isomerase Deficiency

Aug 8, 2019 4:05 pm EDT

Cerecor Reports Second Quarter 2019 Results

Jul 29, 2019 6:30 am EDT

FDA Accepts IND Application for Cerecor’s Investigational Drug CERC-802 for the treatment of MPI-CDG

Jul 15, 2019 6:30 am EDT

Cerecor Announces First Patient Enrolled in CDG FIRST Trial